Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001213296 | SCV001384922 | likely benign | Singleton-Merten syndrome 1; Aicardi-Goutieres syndrome 7 | 2023-12-03 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004033884 | SCV004887720 | likely benign | Inborn genetic diseases | 2022-03-21 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Prevention |
RCV004746273 | SCV005367058 | uncertain significance | IFIH1-related disorder | 2024-04-10 | no assertion criteria provided | clinical testing | The IFIH1 c.2416C>T variant is predicted to result in the amino acid substitution p.Arg806Cys. To our knowledge, this variant has not been reported in the literature. This variant is reported in 0.037% of alleles in individuals of South Asian descent in gnomAD. At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. |